Abstract:Background Dysbiosis of gastric microbiota including Helicobacter pylori (H. pylori) infection is associated with the development of stomach cancer. Probiotics have been shown to attenuate H. pylori‐induced gastritis, although their role in cancer prevention remains unclear. Thus, we aimed to explore the effects of probiotics on H. pylori‐induced carcinogenesis and the alterations of gastrointestinal microbiota. Methods Male INS‐GAS mice were randomly allocated to H. pylori‐infected and non‐infected groups. After 4 weeks, probiotic combination (containing Lactobacillus salivarius and Lactobacillus rhamnosus) was administered in drinking water for 12 weeks. Stomachs were collected for RNA‐Sequencing and the differentially expressed genes were validated using RT profiler PCR array. 16S rRNA gene sequencing was performed to assess the alterations of gastrointestinal microbiota. Results Probiotics significantly alleviate H. pylori‐induced gastric pathology, including reduced infiltration of inflammation and lower incidence of precancerous lesions. RNA‐Sequencing results showed that probiotics treatment decreased expressions of genes involved in pro‐inflammatory pathways, such as NF‐κB, IL‐17, and TNF signaling pathway. Of note, probiotics did not suppress the growth of H. pylori, but dramatically reshaped the structure of both gastric and gut microbiota. The microbial diversity was increased in H. pylori‐infected group after probiotics treatment. While gastric cancer‐associated genera Lactobacillus and Staphylococcus were enriched in the stomach of H. pylori‐infected group, the beneficial short‐chain fatty acids‐producing bacteria, including Bacteroides, Alloprevotella, and Oscellibacter, were more abundant in mice treated with probiotics. Additionally, probiotics restored the H. pylori‐induced reduction of anti‐inflammatory bacterium Faecalibaculum in the gut. Conclusions Probiotics therapy can protect against H. pylori‐associated carcinogenesis probably through remodeling gastrointestinal microbiota, which in turn prevent host cells from malignant transformation.

MicroRNA‐3178 Ameliorates Inflammation and Gastric Carcinogenesis Promoted by Helicobacter Pylori New Toxin, Tip‐α, by Targeting TRAF3

MicroRNA-143-3p, Up-Regulated in H. Pylori-Positive Gastric Cancer, Suppresses Tumor Growth, Migration and Invasion by Directly Targeting AKT2.

MicroRNA-155 Is Essential for the T Cell-Mediated Control of Helicobacter pylori Infection and for the Induction of Chronic Gastritis and Colitis

Epigenetic silencing of microRNA-204 by Helicobacter pylori augments the NF-κB signaling pathway in gastric cancer development and progression

MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application

Association of miR-499 rs3746444, miR-149 rs2292832 polymorphisms and their expression levels with helicobacter pylori-related gastric diseases and Traditional Chinese Medicine syndromes

Mir-140-3p is Involved in the Occurrence and Metastasis of Gastric Cancer by Regulating the Stability of FAM83B

TNF-α-inducing protein of Helicobacter pylori promotes EMT and cancer stem-like cells properties via activation of Wnt/β-catenin signaling pathway in gastric cancer cells.

[Retracted] MicroRNA‑454 Inhibits Tumor Cell Proliferation, Migration and Invasion by Downregulating Zinc Finger E‑box‑binding Homeobox 1 in Gastric Cancer.

Increased infiltration of CD4+IL‐17A+FOXP3+ T cells in Helicobacter pylori‐induced gastritis

Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene ANGPT2 and miR-203a in AGS gastric cell line

Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinib

microRNA-365 inhibits YAP through TLR4-mediated IRF3 phosphorylation and thereby alleviates gastric precancerous lesions

MiR-1298-5p level downregulation induced by Helicobacter pylori infection inhibits autophagy and promotes gastric cancer development by targeting MAP2K6

MicroRNAs Up-Regulated by CagA of Helicobacter Pylori Induce Intestinal Metaplasia of Gastric Epithelial Cells

Helicobacter pylori induces gastric cancer via down‐regulating miR‐375 to inhibit dendritic cell maturation

The role of non-coding RNA in the diagnosis and treatment of Helicobacter pylori-related gastric cancer, with a focus on inflammation and immune response

Overexpression of Tim-3 reduces Helicobacter pylori-associated inflammation through TLR4/NFκB signaling in vitro

Helicobacter pylori Infection Mediates Inflammation and Tumorigenesis-Associated Genes Through miR-155-5p: An Integrative Omics and Bioinformatics-Based Investigation

Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota

NF-kB-dependent activation of STAT3 by H. pylori is suppressed by TFF1